Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs.

Autor:	Barocas JA; Division of Infectious Disease , Massachusetts General Hospital , Boston., Linas BP; Division of Infectious Disease , HIV Epidemiology and Outcomes Research Unit, Boston University Medical Center , Massachusetts., Kim AY; Division of Infectious Disease , Massachusetts General Hospital , Boston., Fangman J; Division of Infectious Disease , Medical College of Wisconsin , Milwaukee., Westergaard RP; Departments of Medicine; Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison.
Jazyk:	angličtina
Zdroj:	Open forum infectious diseases [Open Forum Infect Dis] 2016 Apr 06; Vol. 3 (2), pp. ofw075. Date of Electronic Publication: 2016 Apr 06 (Print Publication: 2016).
DOI:	10.1093/ofid/ofw075
Abstrakt:	People who inject drugs may benefit from point-of-care hepatitis C virus (HCV) testing offered at syringe exchanges. We sought to understand whether this population would be willing to undergo rapid HCV testing. We found that there was broad support for rapid HCV testing, especially among younger people who inject drugs with high perceived risk.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu